- Alan Tribe
- Rohan Hockings, MBBS (Hons) JD GDLP
- Bernard Hockings, RFD, MD, MBBS, FRACP, FCSANZ, GAICD
Alan Tribe | Chairman
Mr Tribe has a background in the accounting profession both in the UK and Australia. Moving into industry he became the Managing Director of a group of companies with interests in natural resources in Australia and overseas. The group also included a technology company which grew through both successful product development and acquisitions.
He was closely involved in establishing subsidiary operations in the USA, UK and Singapore to access markets worldwide.
Most recently he was the catalyst for the development for large retail operations in Western and South Australia.
Mr Tribe will contribute his broad experience in successfully commercialising technology internationally. He represents a large shareholding in Phylogica.
Rohan Hockings, MBBS (Hons) JD GDLP | Director and CEO
Rohan Hockings holds double degrees in medicine and law. He has worked across both disciplines following an internship at Sir Charles Gairdner Hospital and admission to practice in the Supreme Court of Victoria respectively. He spent four years with McKinsey & Company and a further two years in the Private Equity industry before joining Phylogica. Rohan brings a deep affinity for conceptual thinking to Phylogica along with an understanding of the company’s technology and its commercialisation path.
Bernard Hockings RFD, MD, MBBS, FRACP, FCSANZ, GAICD | Non-Executive Director
Dr Hockings was previously an interventional cardiologist and Clinical Associate Professor in Medicine at the University of Western Australia. Past appointments have included Director of the Coronary Care Unit at Royal Perth Hospital, Chair of the Medical Advisory Committee Mount Hospital, Director of the Cardiac Catheterisation Laboratory St John of God Hospital Bunbury and Director of Health Reserves (WA) for the Royal Australian Air Force. Dr Hockings has previously served on the board of the WA branch of the National Heart Foundation.
Dr Hockings has a lifelong interest in medical research. His doctoral thesis concerned vasodilator therapy in the treatment of heart failure.
Dr Hockings is a major shareholder in Phylogica.